Gordon Smith Baxter
About Gordon Smith Baxter
Gordon Smith Baxter is the Chief Scientific Officer at Instem and the founder of Common Stream Publishing, with a background in pharmacology and extensive leadership experience in the life sciences and pharmaceutical industries.
Professional Background
Gordon Smith Baxter holds extensive experience in leadership roles within the life sciences and pharmaceutical industries. He has held positions such as Discovery Project Manager at SmithKline Beecham, Chief Operating Officer at Pharmagene plc, CEO at BioWisdom, and a board member of the Pistoia Alliance. His career trajectory includes significant contributions to drug discovery and development processes, demonstrating a robust track record of innovation and advancements in these fields.
Chief Scientific Officer at Instem
Gordon Smith Baxter currently serves as the Chief Scientific Officer at Instem. Having been with the company since 2011, he plays an instrumental role in advancing their software applications to enhance drug and chemical development processes. His work has been pivotal in increasing client productivity through innovative information solutions in Life Sciences R&D.
Founder of Common Stream Publishing
In 2008, Gordon Smith Baxter founded Common Stream Publishing, based in Cambridge. This venture further signifies his entrepreneurial spirit and dedication to advancing the healthcare and pharmaceutical sectors.
Leadership at BioWisdom Ltd
Gordon Smith Baxter was the founder of BioWisdom Ltd, a UK-based healthcare intelligence company. He served as the CEO from 2000 to 2011, overseeing the company's growth and eventual acquisition by Instem in 2011. His tenure at BioWisdom is marked by his contribution to innovative information solutions for Life Sciences R&D.
Educational Background
Gordon Smith Baxter holds a Bachelor of Science in Biomedical Sciences and a PhD in Biomedical Science, both from the University of Bradford. His academic background in pharmacology has provided a solid foundation for his extensive career in the pharmaceutical and life sciences industries.